Sekwon Jang is a Hematologist Oncology specialist and an Oncologist in Falls Church, Virginia. Dr. Jang is highly rated in 13 conditions, according to our data. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Cutaneous T-Cell Lymphoma (CTCL), and Squamous Cell Skin Carcinoma. Dr. Jang is currently accepting new patients.

Dr. Mark Markowski is a medical oncologist at the Kimmel Cancer Center at Sibley Memorial Hospital, as well as an Associate Professor in the Department of Oncology at Johns Hopkins University School of Medicine. Dr. Markowski participates in multidisciplinary clinics at Sibley and The Johns Hopkins Hospital, and sees patients in the genitourinary clinics of both hospitals. Dr. Markowski treats numerous types of cancers, with a specialty in prostate and kidney cancers. Dr. Markowski earned his medical degree and Ph.D. in tumor biology at Georgetown University School of Medicine. He completed a residency in internal medicine at Columbia University, followed by a medical oncology fellowship at Johns Hopkins Hospital. Dr. Markowski previously served as a research associate at the Lombardi Comprehensive Cancer Center at Georgetown University. His research interests focus on early phase drug development for prostate cancer, as well a non-castrating therapies for patients with metastatic disease. Dr. Markowski is currently conducting research with funding from a Department of Defense Prostate Cancer Research Program Award and a Challenge Award from the Prostate Cancer Foundation, which focuses on new treatment strategies for prostate cancer patients. Dr. Markowski is highly rated in 12 conditions, according to our data. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Wilms Tumor, Hormone Replacement Therapy (HRT), and Prostatectomy.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is highly rated in 62 conditions, according to our data. His top areas of expertise are Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Splenectomy.

Mark Goldstein is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Goldstein is highly rated in 30 conditions, according to our data. His top areas of expertise are Childhood Iron Deficiency Anemia, Anal Cancer, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma.

Dr. Benjamin Levy is a thoracic medical oncologist and the clinical director of medical oncology for the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, as well as an associate professor of oncology for Johns Hopkins University School of Medicine. He practices out of the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital. Dr. Levy is a physician scientist who is interested in innovative immunotherapeutic approaches for advanced stage lung cancer patients and biomarkers that help define those patients more likely to respond to such agents. He has an expertise in thoracic malignancies, including non-small cell lung cancer, small cell lung cancer and thymic malignancies, as well as head and neck cancer. Dr. Levy earned his medical degree from Medical College of Georgia. He completed an internal medicine residency at Georgetown University Hospital, followed by a hematology/oncology fellowship at New York Presbyterian/Weill Cornell Medical Center, where he received the Department of Medicine Research Fellow of the Year Award and the 2009 American Society of Clinical Oncology Young Investigator Award for his clinical research in prostate cancer. Dr. Levy previously worked as an assistant professor at the Icahn School of Medicine, medical director of thoracic oncology for Mount Sinai Health Systems and associate director of the Cancer Clinical Trials Office for Mount Sinai Hospital in New York City. Dr. Levy played an integral role on several American Society of Clinical Oncology (ASCO) committees and currently serves as associate editor for the ASCO University Committee. He completed a two year term on the editorial board for the Journal of Clinical Oncology and currently serves as an ad hoc reviewer for other journals, including Clinical Lung Cancer, The Oncologist and Oncotarget. Dr. Levy was recently selected as one of only 15 oncologists in the country to the prestigious ASCO Leadership Development program, whose mission is to identify and develop future leaders of ASCO. In addition to his ASCO commitments, Dr. Levy serves on the ALLIANCE Respiratory Committee, the IASLC Staging Committee and the IASLC Career Development & Fellowship Committee. Dr. Levy is highly rated in 9 conditions, according to our data. His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma.

"Dr. Ari D. Fishman is a hematologist affiliated with Sibley Memorial Hospital, Holy Cross Hospital and George Washington University Hospital, where he serves as an assistant professor of medicine for the School of Medicine. He practices out of Maryland Oncology and Hematology, located in Wheaton, Maryland and Silver Spring, Maryland. Dr. Fishman earned his medical degree from Sackler School of Medicine. He completed a residency in internal medicine at the Beth Israel Medical Center, followed by a fellowship in hematology and oncology at the Montefiore Medical Center. Dr. Fishman previously worked at Washington Oncology Hematology Center, located in Washington, D.C. and Chevy Chase, Maryland. Dr. Fishman has been named a Top Doctor in Hematology and Oncology by Washingtonian Magazine and a Top Doctor by Consumers’ Checkbook magazine. Dr. Fishman is a member of the American College of Physicians and the American Society of Clinical Oncology. Dr. Fishman has contributed to numerous publications. Selected Publications Fishman AD, Hoffman A, Volterra F, Frymus M, Gentilluci M. ""Intracaval and intracardiac metastatic nonseminomatous germ cell tumor: a rare cause of hemolytic anemia and thrombocytopenia."" Cancer Invest. 2002;20(7-8):996-1001.". Dr. Fishman is highly rated in 55 conditions, according to our data. His top areas of expertise are Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndrome (MDS), and Childhood Iron Deficiency Anemia.

Nicholas Farrell is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Farrell is highly rated in 47 conditions, according to our data. His top areas of expertise are Lung Cancer, Childhood Iron Deficiency Anemia, Pleuropulmonary Blastoma, and Iron Deficiency Anemia.

John Marshall is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Marshall is highly rated in 13 conditions, according to our data. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, Hepatectomy, and Pancreatectomy.

Neelima Denduluri is a Hematologist Oncology provider in Arlington, Virginia. Dr. Denduluri is highly rated in 5 conditions, according to our data. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Pleuropulmonary Blastoma, and HER2 Negative Breast Cancer. Dr. Denduluri is currently accepting new patients.

Claudine Isaacs is a Hematologist Oncology specialist and an Oncologist in Washington, Washington, D.c.. Dr. Isaacs is highly rated in 12 conditions, according to our data. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, HER-2 Positive Breast Cancer, Angiosarcoma, and Salpingo-Oophorectomy.

Neal Young is a Hematologist in Bethesda, Maryland. Dr. Young is highly rated in 11 conditions, according to our data. His top areas of expertise are Aplastic Anemia, Anemia, Paroxysmal Cold Hemoglobinuria, Paroxysmal Nocturnal Hemoglobinuria (PNH), and Bone Marrow Transplant.

Phillip Scheinberg is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Scheinberg is highly rated in 7 conditions, according to our data. His top areas of expertise are Aplastic Anemia, Anemia, Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, and Bone Marrow Transplant.

Sandra Swain is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Swain is highly rated in 6 conditions, according to our data. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, HER-2 Positive Breast Cancer, and Febrile Neutropenia.

Geoffrey Gibney is a Hematologist and an Oncologist in Washington, Washington, D.c.. Dr. Gibney is highly rated in 5 conditions, according to our data. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Olfactory Neuroblastoma, and Sinus Cancer.

Keeran Sampat is a Hematologist and an Oncologist in Arlington, Virginia. Dr. Sampat is highly rated in 54 conditions, according to our data. His top areas of expertise are Anal Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Paget Disease of the Breast.

Steven Pavletic is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Pavletic is highly rated in 4 conditions, according to our data. His top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Graft.

Dr. Sarah Waheed is a fellowship-trained oncologist specializing in the treatment of complex blood cancers including multiple myeloma, smoldering myeloma, amyloidosis, light chain disposition disease, monoclonal gammopathy (MGUS), POEMS and Waldenstrom’s macroglobulinemia. Her research on blood cancer treatments, transplant techniques and innovations are frequently published in peer-reviewed journals. As a member of the Johns Hopkins Kimmel Cancer Center’s blood cancers program at Sibley Memorial Hospital, Dr. Waheed is part of a team that is available 24/7 to evaluate, admit, diagnose and treat patients with same day appointments or through the emergency department. The Blood Cancer Program at Sibley is integrated with the Bone Marrow Transplant Program at The Johns Hopkins Hospital and can refer for stem cell transplant. Patients are able to receive care locally before and after the transplant. Dr. Waheed is highly rated in 3 conditions, according to our data. Her top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, and Monoclonal Gammopathy of Undetermined Significance (MGUS).

Jillian Simard is a fellowship-trained medical oncologist with a focus on breast cancer. She sees patients at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, and is a clinical associate for the Johns Hopkins University School of Medicine. Dr. Simard brings a multidisciplinary background in patient care, translational research and clinical trials, with a particular interest in improving outcomes for patients with breast cancer through personalized and evidence-based treatment strategies. Dr. Simard received her medical degree from the UCSF School of Medicine, followed by a residency in internal medicine at Northwestern University McGaw Medical Center, where she was part of the Women’s Health Track and received a Resident Teaching Award. She then completed a clinical fellowship in medical oncology at the National Cancer Institute (NCI), where she also served as a research fellow in the Lymphoid Malignancies Branch. During her time at the NCI, Dr. Simard participated in multiple clinical research efforts, including serving as lead associate investigator for a Phase 2 trial for secondary CNS lymphoma. Her research portfolio includes designing early-phase clinical trials and contributing to peer-reviewed publications in journals such as the New England Journal of Medicine and Clinical Lymphoma, Myeloma & Leukemia. Dr. Simard is committed to fostering compassionate, equitable care and to working collaboratively across disciplines to improve patient outcomes. Dr. Simard is highly rated in 1 condition, according to our data. Her top areas of expertise are Febrile Neutropenia, Agranulocytosis, B-Cell Lymphoma, and Non-Hodgkin Lymphoma.

Catherine Broome is a Hematologist in Washington, Washington, D.c.. Dr. Broome is highly rated in 29 conditions, according to our data. Her top areas of expertise are Autoimmune Hemolytic Anemia, Chronic B-Cell Leukemia (CBCL), Thrombocytopenia, Bone Marrow Aspiration, and Splenectomy.

Craig Kessler is a Hematologist in Washington, Washington, D.c.. Dr. Kessler is highly rated in 22 conditions, according to our data. His top areas of expertise are Blood Clots, Hemophilia A, Acquired Hemophilia, Bone Marrow Aspiration, and Splenectomy.

Bruce Cheson is a Hematologist and a Hematologist Oncology provider in Bethesda, Maryland. Dr. Cheson is highly rated in 18 conditions, according to our data. His top areas of expertise are Follicular Lymphoma, Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma, and Bone Marrow Transplant. Dr. Cheson is currently accepting new patients.

Benjamin Weinberg is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Weinberg is highly rated in 16 conditions, according to our data. His top areas of expertise are Colorectal Cancer, Pancreatic Cancer, Familial Colorectal Cancer, Vertebroplasty, and Colonoscopy. Dr. Weinberg is currently accepting new patients.

Mark Roschewski is a Hematologist in Washington, Washington, D.c.. Dr. Roschewski is highly rated in 13 conditions, according to our data. His top areas of expertise are B-Cell Lymphoma, Smoldering Multiple Myeloma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Vitrectomy.

Dr. James Xu received a bachelor of science in chemical engineering with a minor in mathematics from Brigham Young University and his medical degree from University of Minnesota. He completed his internal medicine residency at the Yale-New Haven Hospital of Yale University in New Haven, CT, and his hematology and medical oncology fellowship at the New York-Presbyterian Hospital of Columbia University in New York City. Because of his unique background in engineering and medicine, Dr. Xu was the recipient of the American Society of Clinical Oncology-Conquer Cancer Foundation Young Investigator Award in 2011 and Merit Award in 2012. Dr. Xu is a strong advocate of precision medicine and he is the first person to have proposed and preliminarily confirmed the feasibility of using deep sequencing technology to detect genetic mutation in rare cell samples such as circulating tumor cells from cancer patients’ peripheral blood. He has published in peer-reviewed journals in lung, breast, and pancreatic cancers. Dr. Xu is highly rated in 10 conditions, according to our data. His top areas of expertise are Pulmonary Embolism, Deep Vein Thrombosis, Protein S Deficiency, and Congenital Antithrombin 3 Deficiency.

James Gulley is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Gulley is highly rated in 8 conditions, according to our data. His top areas of expertise are Prostate Cancer, Olfactory Neuroblastoma, Chordoma, Urothelial Cancer, and Orchiectomy.